Multiple sclerosis

  • Chance to influence MS drug appraisal decision

    Chance to influence MS drug appraisal decision

    Siponimod, a tablet taken once daily to treat secondary progressive MS (SPMS), is currently under investigation by NICE to assess whether it should be available via an NHS prescription in England and Wales. Scotland and Northern Ireland will carry out separate appraisals. National charity the MS Trust plans to make a compelling case to NICE in favour of the drug being available on the NHS – and needs input from people with MS and those who work with MS patients.

  • MS register gets £1m funding boost

    MS register gets £1m funding boost

    The UK MS Register, based at Swansea University, was established in 2011 as the first nationwide register of its kind. It seeks to gather information from people with MS about what it’s like to live day-to-day with the condition. This information provides rich, anonymised data for the purposes of medical research, which could unlock some of the mysteries behind the disease.